BDBM287601 US10420768, Compound C-12::US9567341, Compound C-12

SMILES FC(F)(CN1CCC(CC1)Nc1ncnc2[nH]ccc12)c1ccccn1

InChI Key InChIKey=MAXUFZSXJOBXDK-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 287601   

TargetGlutamate receptor ionotropic, NMDA 2A(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM287601(US10420768, Compound C-12 | US9567341, Compound C-...)
Affinity DataIC50: >1.00E+7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2A(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM287601(US10420768, Compound C-12 | US9567341, Compound C-...)
Affinity DataIC50: >1.00E+7nMpH: 7.4Assay Description:Inhibitory activities of test compounds on 5 major isoforms of CYP P450 were evaluated by using pooled human liver microsome (HLM, purchased from BD ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent